Readers discuss an essay about whether it is a disease and how it should be diagnosed. Also: Fear in schools; natural ...

Roche said on Monday that three early-stage obesity and diabetes drug candidates from its acquisition of Carmot Therapeutics ...

More than a quarter of Year 6 school pupils in a borough are obese according to a new report, with the rate more than ...

More from Scotland's papers. The Herald. The Scotsman. Daily Record. The Scottish Sun. Daily Mail. Scottish Daily Express.

At least 1 in 5 adults in each U.S. state live with obesity, new data from the Centers for Disease Control and Prevention ...

Obesity is high and holding steady in the U.S., but the proportion of those with severe obesity — especially women — has ...

A clear FDA public education campaign could help shoppers make healthier choices. But it should first pay attention to the ...

Roche argued that its obesity medications would prove to have advantages over its rivals’ — and that the demand for weight ...

Roche (RHHBY) reportedly sees three obesity/diabetes drug candidates acquired through its takeover of Carmot having the ...

Rivus already announced in August that the trial hit its key endpoint, but today fleshed out that win with some figures.

Roche focuses on obesity drug development, fast-tracking its CT-388 candidate, and targeting $3.6 billion in annual sales.

Obesity—the bad word everyone throws around, but few want to truly understand. The American Academy of Pediatricians thought ...